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Background: Although the germicidal properties of UV light have long been known it is only 27 
comparatively recently that the antimicrobial properties of visible violet-blue 405 nm light have 28 
been discovered and utilised for environmental disinfection and infection control applications. 29 
Aim: To review the antimicrobial properties of 405 nm light and describe its application as an 30 
environmental decontamination technology with particular reference to disinfection of the 31 
hospital environment. 32 
Methods: Extensive literature searches for relevant scientific papers and reports. 33 
Findings: A large body of scientific evidence is now available that provides underpinning 34 
knowledge of the 405 nm light induced photodynamic inactivation process involved in the 35 
destruction of a wide range of prokaryotic and eukaryotic microbial species including resistant 36 
forms such as bacterial and fungal spores. For practical application, an environmental 37 
disinfection system (HINS-light EDS) has been developed and tested in hospital isolation rooms. 38 
The trial results have demonstrated that this 405 nm light system can provide continuous 39 
disinfection of air and exposed surfaces in occupied areas of the hospital, thereby substantially 40 
enhancing standard cleaning and infection control procedures. 41 
Conclusions: Violet-blue light, particularly 405 nm light, has significant antimicrobial properties 42 
against a wide range of bacterial and fungal pathogens and, although germicidal efficacy is 43 
lower than UV-light, this limitation is offset by its facility for safe continuous use in occupied 44 
environments.  Promising results on disinfection efficacy have been obtained in hospital trials 45 
but the full impact of this technology on reduction of HAI has yet to be determined.  46 
 47 
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Although intensive efforts over recent years are making an impact, healthcare-associated 56 
infections (HAI) still regularly occur and continue to pose a major challenge.  In addition to the 57 
significant morbidity and financial costs, concern over contraction of a HAI is one of the greatest 58 
fears of patients being admitted to hospital.1  Infection control procedures such as hand washing 59 
are of critical importance in addressing the HAI problem, however greater awareness of the 60 
hospital environment as a source of nosocomial pathogens has led to renewed focus on hospital 61 
cleaning and disinfection.  Whilst effective physical cleaning remains essential for infection 62 
control and aesthetic reasons, there has been an upsurge of interest in the development of new 63 
cleaning and decontamination technologies.2,3  A number of these employ novel methods of 64 
delivering antimicrobial chemicals, whereas others use the antimicrobial properties of light to 65 
enhance disinfection,4,5,6 and it is this latter approach that forms the topic of this review. 66 
The most germicidal wavelengths of light fall within the ultraviolet (UV) range and UVC 67 
(between 240-260 nm) irradiation has traditionally been used for disinfection, particularly for 68 
air and medical device decontamination applications.7,8,9 More recently the antimicrobial 69 
properties of violet-blue visible light has emerged as an area of increasing research interest.  70 
Although less germicidal than UVC light, violet-blue light with wavelengths in the region of 71 
405 nm, has proved effective for inactivation of a range of microbial species, and exploitation of 72 
these wavelengths may provide alternative methods of antimicrobial treatment for infection 73 
control applications.  This paper will provide a brief background on the use of light for 74 
environmental decontamination applications within hospitals before presenting a detailed 75 
description of the broad spectrum antimicrobial effects of violet-blue light and how this 76 
knowledge has led to the development and clinical evaluation of a 405 nm light environmental 77 
disinfection system.  In addition to environmental decontamination applications, other potential 78 
uses of violet-blue light for infection control proposes such as skin and wound treatment have 79 
been highlighted in recent literature but these topics are out with the scope of the current 80 
review.10-17 81 
Inactivation of microorganisms by light in the hospital environment 82 
Records of observations on the antibacterial effects of light go back to the latter part of the 19th 83 
century and these early historical observations have been documented by Kowalski.18  The 84 
germicidal effects of light received further attention during the early part of the 20th century and 85 
the appreciation of the decontamination effect of light was translated into early hospital design 86 
features where natural ventilation and exposure to sunlight were regarded as beneficial.19  The 87 
roles of sunlight and natural ventilation for controlling the transmission of infections within 88 
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healthcare settings has recently been reviewed by Hobday and Dancer, who provide a detailed 89 
record of the early Ȃ mid 20th century observations on the effects of natural sunlight on a wide 90 
range of nosocomial pathogens.20  Whilst natural light and ventilation were originally 91 
considered beneficial, modern hospital design has tended to reduce these features.  Recent 92 Ǯǯregard to energy 93 
reduction issues but also how lighting can affect the mood and circadian rhythm of patients.21,22 94 
Light from artificial sources with wavelength emission in the UV range, can have significant 95 
antimicrobial effects and new technologies for hospital decontamination have been developed 96 
around this concept.6,23-25 97 
The most widespread applications of ultra-violet germicidal irradiation (UVGI) has been for air 98 
and water disinfection, as well as for decontamination of devices.26-28  More recently, with the 99 
increased emphasis that has been directed towards enhanced decontamination of the hospital 100 
environment, novel technologies have been developed for the rapid delivery of UVC radiation to 101 
exposed surfaces in clinical areas.  Several of these are automated or manually positioned 102 
robotic systems using either continuous or pulsed UV emission sources.6,25 Detailed information 103 
on UVGI   Ǯ-ǯ      provided in a recent 104 
review by Otter et al.6 105 
Antimicrobial Effects of Violet-Blue Light 106 
Until relatively recently light within the visible spectrum (400Ȃ700 nm) was considered to have 107 
little biocidal effect compared to UVC light due to the lower photon energy of these wavelengths.  108 
Wavelengths of violet-blue light, particularly around 405 nm, have however been shown to 109 
possess antimicrobial capabilities, and there is scope for exploiting these wavelengths for the 110 
control of problematic microorganisms in many areas of application including the disinfection 111 
of air and exposed surfaces in the clinical environment.  The following section provides an 112 
overview of the antimicrobial inactivation mechanism, and the antimicrobial efficacy of high-113 
intensity 405 nm violet-blue light. 114 
Violet-Blue Light Inactivation Mechanism 115 
Investigations into the mechanism of action of 405 nm violet-blue light indicate that 116 
photodynamic inactivation occurs as a result of the photo-excitation of intracellular porphyrin 117 
molecules within the exposed bacterial cells.  Laboratory studies have shown that a range of 118 
violet-blue light wavelengths in the region 400-425 nm can be used for bacterial inactivation,29-119 
34 however, optimal antimicrobial activity has been found at 405 nm.34,35  This peak in activity 120 
correlates with the absorption maximum of porphyrin molecules, termed the soret band, being 121 
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in this wavelength region.36  Exposure to light of this wavelength induces an oxygen dependent 122 
photo-excitation reaction within exposed microorganisms, where excited porphyrins react with 123 
oxygen or cell components to produce reactive oxygen species (ROS) causing oxidative damage 124 
and microbial cell death.29,37-41  Cell death has been accredited to oxidative damage to the cell 125 
membrane, with a recent study demonstrating disruption of the cytoplasmic content and cell 126 
walls of exposed S. aureus,10 and it is likely that, due to the non-selective nature of ROS, multi-127 
target damage will be induced in the microbial cells. 128 
Antimicrobial Effects of Violet-Blue Light 129 
Extensive laboratory studies have shown that 405 nm light, and the wider violet-blue light 130 
wavelengths, have a broad spectrum of activity, with successful inactivation demonstrated for a 131 
wide range of organisms, including antibiotic-resistant bacterial strains such as methicillin-132 
resistant Staphylococcus aureus (MRSA).30-32  Bacterial species which have demonstrated 133 
susceptibility include HAI-associated organisms, including Staphylococcus aureus, Clostridium 134 
difficile, Acinetobacter baumanni, Escherichia coli, Staphylococcus epidermidis, Pseudomonas 135 
aeruginosa, Klebsiella pneumoniae, Streptococcus pyogenes and Mycobacterium species.29-33,42,43  136 
Bacterial sensitivity to violet-blue light inactivation tends to be species dependent, however the 137 
general trend suggests that Gram positive bacteria tend to be more susceptible to inactivation 138 
than Gram negative species.32,44 139 
Two of the most significant pathogens associated with HAI are MRSA and C. difficile, and 140 
vegetative cells of these species both show susceptibility to violet-blue light inactivation.  141 
Vegetative cells of C. difficile are particularly sensitive to inactivation, and this is likely to be due 142 
to this organism being an obligate anaerobe, giving it increased sensitivity to oxidative 143 
damage.33  C. difficile spores are a significant issue for infection control, particularly due to their 144 
prolonged survival in the environment, and their resilience to disinfection technologies is well 145 
documented.45-47 C. difficile spores can be successfully inactivated by exposure to 405 nm light, 146 
however as expected, significantly higher doses (~50 times) are required for inactivation 147 
compared to vegetative cells.33 148 
Laboratory studies have demonstrated the successful antimicrobial efficacy of violet-blue light 149 
for the inactivation of bacterial contamination in liquid,10,11,29,32,34 artificially seeded on 150 
surfaces,30,31,42,48 and most recently, in biofilms.44  Within the clinical environment, biofilm 151 
formation is a major cross-contamination risk, with the presence of patient fluids such as saliva, 152 
blood and urine influencing biofilm adhesion and development on surfaces.49  Indeed, a recent 153 
study attributed the presence of Pseudomonas aeruginosa biofilms on sinks to the acquisition of 154 
infections, with a 33% death rate.50 155 
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Although the germicidal efficacy of blue light is lower than that of ultraviolet light Ȃ UV 156 
inactivation typically required doses of the order of mili-joules rather than joules as is the case 157 
with violet-blue light 51,52 Ȃ significant bacterial inactivation can still be demonstrated, with up 158 
to 9-log10 orders of reduction being achieved in one study.32  A major advantage of violet-blue 159 
light inactivation is that the susceptibility of strains isolated from the clinical environment is 160 
similar to their laboratory type strain counterparts i.e. clinical isolates do not show enhanced 161 
resistance and thus can be inactivated by 405 nm light with no inherent problems.32  Also, it has 162 
recently been demonstrated that sublethally damaged bacterial cells are more susceptible to 163 
light inactivation48, therefore, there is great potential for bacterial contamination that has been 164 
sub-lethally stressed by desiccation and disinfectants during routine cleaning of the hospital 165 
environment to be more susceptible to inactivation by exposure to violet-blue light. 166 
In addition to clinically relevant bacteria, the effectiveness of 405 nm light for microbial 167 
inactivation has also been demonstrated against bacterial species associated with foodborne 168 
infection including Listeria, Campylobacter, Shigella and Salmonella species;32,34,53 pathogens 169 
Helicobacter pylori, Chlamydia and Propionibacterium acnes;29,37,43 oral periodontal 170 
pathogens;54,55 and fungal organisms including moulds and yeasts such as Candida.56  To date 171 
the effect of violet-blue light on viruses has not been fully determined, however it is expected 172 
that due to the hypothesised involvement of porphyrins in the inactivation mechanism, it is 173 
unlikely that viruses will be highly susceptible to light exposure alone, and may require the 174 
addition of photosensitising material to enhance viricidal activity.57  175 
Use of 405 nm Violet-Blue Light for Hospital Disinfection 176 
The wide antimicrobial spectrum of activity combined with the ability to apply light intensities 177 
safe for human exposure make violet-blue light ideal for decontamination of occupied 178 
environments, and the development of a system which utilises high-intensity narrow spectrum 179 
(HINS) 405 nm light for environmental disinfection of the clinical environment has been 180 
recently described.58-60  This new disinfection technology, termed the HINS-light Environmental 181 
Decontamination System (EDS) is a ceiling-mounted lighting system designed for the reduction 182 
of environmental contamination in hospital wards and other areas of the healthcare 183 
environment.  The antimicrobial light from the system is generated from a matrix of light-184 
emitting diodes (LEDs) which emit low irradiance violet-blue light with a narrow spectral 185 
profile centred on 405 nm.58  The output of the antimicrobial light has been set to ensure, with 186 
reference to international guidelines,61,62 that the light source does not pose a blue light hazard 187 
and is safe for use in occupied environments.  Whilst biocidal, the 405 nm wavelengths is well 188 
below the blue light wavelengths which can impact on human health, particularly in the region 189 
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of 440 nm which is associated with photoretinitis, and 480 nm which is influences mood and 190 
circadian rhythm in humans, as shown in Figure 1.  Whilst satisfying safety standards as an 191 
installed light source it is interesting to also note that, when comparing the susceptibility of 192 
mammalian cells and bacteria to 405 nm light, mammalian keratinocytes and osteoblasts were 193 
considerably more resistant and could be exposed to bactericidal levels of 405 nm light with no 194 
loss of cell viability.10,11,63  The increased resistance of mammalian cells is likely due to the fact 195 
that these cells have much more advanced mechanisms for coping with oxidative damage 196 
compared to the more primitive microbial cells. 197 
For practical application as an overhead light source, incorporation of white LEDs into the HINS-198 
light EDS system ensures the illumination output is predominantly white, thus blending with 199 
the standard room lighting.58  The system is designed to be operated continuously, providing 200 
on-going disinfection of the air and all exposed environmental surfaces within the treated area, 201 
with no disruption to day-to-day hospital procedures or patient care.  Laboratory testing of the 202 
system confirms the efficacy for inactivation of a range of bacterial pathogens associated with 203 
HAI.64  As mentioned, the low irradiance levels employed by the system were deliberately 204 
selected to enable continuous disinfection in occupied environments, and therefore require 205 
sufficient time to exert the antimicrobial effect.  Significant inactivation of microbial 206 
contamination on simulated laboratory surfaces can be achieved by approximately 1-2 h light 207 
exposure,64 however, inactivation kinetics are likely to be significantly enhanced   Ǯǯ208 
clinical environment due to the stressed and dessicated state of the microorganisms.48 209 
Clinical Assessment of 405nm Light for Environmental Disinfection 210 
A number of published studies have presented results from clinical assessment of this 405 nm 211 
light system for continuous environmental decontamination of single-bed isolation rooms.58-60  212 
Evaluation of the technology has been carried out in isolation rooms within two main clinical 213 
areas: a Burns Unit and an Intensive Care Unit (ICU). 214 
For evaluation, systems were installed within isolation rooms, and used as a complementary 215 
disinfection procedure, being operated continuously during daylight hours in occupied rooms, 216 
under conditions where normal clinical care and infection control measures were implemented.  217 
The effect of the system was assessed through contact-plate sampling of bacterial levels on a 218 
range of frequently touched contact surfaces (e.g. locker top, bed table, bed rails, bin lids, light 219 
switches & door handles) which are commonly associated with  Ǯ-ǯ  220 
cross-transmission of HAIs, as well as surfaces likely to have high contamination levels due to 221 
aerial deposition, such as ledges.  Samples were typically collected (i) before use, (ii) during use, 222 
and (iii) a period after the HINS-light EDS units had been switched off, with the same contact 223 
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surfaces sampled throughout each study.  Bacterial levels were assessed using 55 mm contact 224 
agar plates, with a surface area of 23.76 cm2, which were inoculated by pressing the agar 225 
surface onto the environmental surface.  Studies monitored the levels of staphylococcal bacteria 226 
(a good indicator of contamination of human origin),58-60 and the total viable bacteria levels60 in 227 
order to establish the effect of the system for reducing levels of bacterial contamination around 228 
the isolation room.  For collection of staphylococcal organisms, Baird Parker with egg yolk 229 
telurite agar (BPA), a selective medium for the growth of staphylococcal-type organisms, 230 
contact plates were used.  Tryptone soya agar contact plates (TSA), which use non-selective 231 
growth medium, were used to obtain total viable bacterial counts (TVC). Microbiological 232 
assessment, as colony forming unit (CFU) counts, was based upon growth on the contact agar 233 
plates after incubation at 37°C for 24 hours (TSA plates) or 48-hours (BPA plates). 234 
A number of studies also characterised the staphylococcal isolates by subculturing selected 235 
isolates and then testing using Staphaurex Plus (Remel Europe Ltd, Dartford, UK) and PBP2 236 
Latex Agglutination Test (Oxoid Ltd), to identify S. aureus and methicillin S. aureus isolates, 237 
respectively. 238 
Inpatient Studies 239 
An initial study evaluated use of the system for disinfection of an unoccupied isolation room, 240 
and results demonstrated a significant 90% reduction (P=0.000) in the staphylococcal 241 
contamination on surfaces around the room after 24-hour use.58  Studies in burns isolation 242 
rooms occupied by MRSA positive patients, with treatment periods ranging from 2-7 days, 243 
demonstrated that staphylococcal contamination on surfaces around the rooms were 244 
significantly reduced by 56 to 86%, over and above the reductions achieved by cleaning alone.  245 
Levels of presumptive S. aureus and MRSA showed similar reductions.58 Significantly, once use 246 
of the system ceased, recontamination of the room was observed, to levels similar to pre-247 
treatment contamination levels.   248 
An example of the data from one published study is shown in Figure 2, which demonstrates the 249 
mean reductions in the total staphylococcal counts and the presumptive S. aureus levels in an 250 
occupied burns unit isolation room, before, during and after 5-day use of HINS-light EDS.  251 
Samples (n=70) were collected twice during each of the three phases, and the results from all 252 
sampled surfaces have been pooled to demonstrate the overall decontamination effect the 253 
system had across the room.  In this study, data demonstrated that a significant 62% decrease in 254 
total staphylococcal counts, and 50% decrease in presumptive S. aureus was achieved (P<0.05) 255 
after 5-days use of the systemǤ  Ǯ ǯ ǡ lected during a 6-day period after the 256 
system had been turned off, showed that contamination around the room had significantly 257 
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risen, with a 126% and 98% increase in the total staphylococci and presumptive S. aureus 258 
counts, respectively (P<0.05), thus reinforcing the recontamination effect that occurs after 259 
removal of the light-treatment.58  Extended use of the system also proved to further reduce the 260 
bacterial contamination around the room, supporting the continuous use of this system for 261 
maintaining low contamination levels around isolation rooms.58  Importantly, studies were 262 
performed to show that the decontamination effect was not patient or room dependent.59  263 
Studies carried out in an ICU isolation room also demonstrated system efficacy, with 60 to 70% 264 
reductions in both the staphylococcal and the total bacterial contamination across the entire 265 
sampled room environment.60  In addition to demonstrating an overall reduction in 266 
contamination around the room, results demonstrated that exposed surfaces had reduced 267 
contamination levels as a result of use of the system, and an example of this is shown in Figure 268 
3.  Levels of bacteria on various surfaces around an occupied ICU isolation room were 269 
determined before use of the HINS-light EDS, and resampled after a 5-day exposure period.  270 
Results demonstrated that despite marked variation in the initial bacterial bioburden there was 271 
a marked decrease in levels of bacterial contamination at all tested sites. 272 
In addition to these findings, a significant factor noted in the studies carried out in the ICU 273 
isolation room was that despite asymmetrical positioning of the EDS units within the room, 274 
results demonstrated that the special distribution of bacterial contamination was reduced 275 
almost uniformly across all the sampled contact surfaces.  This suggested that disinfection of 276 
airborne bacteria contributes to the reductions in bacterial contamination levels, and the 277 
installation positions of the systems may not be critical.60 278 
Outpatient studies 279 
In addition to its use for disinfection of occupied inpatient isolation rooms, the HINS-light EDS 280 
has also proved effective when used in an outpatient clinic.59  Communal use of outpatient clinic 281 
rooms provides a recognised risk of cross-contamination between subsequently treated 282 
patients, therefore it is important to maintain cleanliness in these areas throughout the day.  283 
Studies carried were carried out to evaluate the environmental bacterial levels at the start and 284 
end of 8-hour clinic sessions, with and without use of the EDS.  Results demonstrated that a 285 
statistically significant 61% efficacy was achieved (P=0.02), and these successful results lead to 286 
the suggestion that use of this system would be beneficial in other similar communal patient 287 
rooms such as the bathroom or physiotherapy room, where decontamination of all surfaces is 288 
unachievable between each patient due to time limitations.59 289 
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Overall, results have been successful, showing evidence that use of 405 nm light achieves 290 
significant reductions in bacterial contamination levels around isolation room environments.58-291 
60  Results also demonstrated that when switched off, the decontamination effect ceases and 292 
bacterial contamination levels return to around pre-treatment levels, further confirming the 293 
effectiveness of the 405 nm light.  It is important to note that these results were achieved under 294 
a range of clinical conditions within a busy city hospital environment, and that the bacterial 295 
disinfection results obtained         ǯ 296 
stringent infection control procedures which remained fully in place throughout the study.58-60  297 
Further studies are still required to establish the effectiveness of 405 nm light for disinfection of 298 
larger communal environments. 299 
 300 
Comparison of 405 nm Light with Other Environmental Decontamination Systems 301 
The increased awareness of the importance of the hospital environment as a source of 302 
nosocomial pathogens has focused attention not only on improving the efficiency of 303 
conventional cleaning and disinfection procedures, but has led to the development of a range of 304 
novel technologies for enhanced decontamination of whole room environments, including new 305 
UV systems (as discussed earlier), steam cleaning, hydrogen peroxide vapour and super-306 
oxidised water fogging.7,65-67  Although these systems are effective for widespread disinfection of 307 
the room environment, they require, for safety reasons, experienced operator supervision and 308 
their use is restricted to unoccupied, sealed rooms, thereby resulting in rooms being out-of-309 
commission for periods of time Ȃ a consequence which can be costly and undesirable in busy 310 
ward areas.  Additionally, whilst these systems provide effective decontamination, studies have 311 
found that once treatment has finished, there is rapid and widespread recontamination of the 312 
room.68  In addition to human safety considerations, another problem associated with UV-light 313 
and chemically-based technologies is the potential for long-term material degradation of 314 
furniture and equipment within the treated room if these are repeatedly exposed.69,70  Therefore 315 
these methods are best-suited for terminal- and deep-cleaning procedures, but are ineffective 316 
for maintaining low levels of contamination. 317 
Whilst UV irradiation and 405 nm light technology share some similar features they are, in 318 
many respects quite distinct technologies both in their modes of action and methods of 319 
application (Table I and Fig. 1).  Whilst UV light is strongly germicidal it is dangerous to humans 320 
and the different UV waveband regions corresponding to UVC, UVB and UVA can cause a wide 321 
range of detrimental effects on the human eye and skin.70  Violet-blue within the visible 322 
spectrum can also cause harmful effects at high irradiance levels but these are particularly at 323 
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440 nm which can cause photoretinitis,61,62 and 480 nm which is the peak sensitivity of 324 
mammalian photosensitive retinal ganglion cells (pRGCs) which modulate diverse physiological 325 
responses to light, including circadian physiology and pupil constriction.76  A comparison of the 326 
biological effects of radiation extending from the UV and into the visible light regions is 327 
presented in Figure 1.  Whilst 405 nm light is germicidal it falls within a relatively benign 328 
wavelength region and if operated at appropriate irradiance levels it is safe for human 329 
exposure.61,62 330 
The above features explain why the 405 nm light environmental disinfection technology, in 331 
comparison with other whole-room decontamination systems including UV technology, can be 332 
operated continuously in the presence of patients and staff, thus facilitating a background 333 
decontamination effect which maintains low levels of contamination.58-60  Continuous operation 334 
of the 405 nm light system ensures that there is a level of disinfection concurrently being 335 
applied even during periods of high activity, such as visiting hours, and bed and bandage 336 
changing.77,78 Whilst disinfectant cleaning and hand hygiene are critical for maintaining a clean 337 
environment and minimising the spread of potential pathogens, compliance with hand-washing 338 
tends to be low after direct contact with a patient, and significantly, healthcare workers are 339 
even less likely to wash their hands after being in contact with the environmental surfaces 340 
around the patients, even though these surfaces can be reservoirs of potential pathogens.79  Use 341 
of the 405 nm light technology can strategically augment this by enhancing the low levels of 342 
contamination achieved with intermittent cleaning, and also provide decontamination of 343 
surfaces within rooms, such as walls and high ledges, as well as delicate equipment, which may 344 
not be routinely cleaned using disinfectants.  Moreover the system can be automatically 345 
operated with no user training required, and consequently problems with staff and patient 346 
compliance do not apply.58-60 347 
As with all methods of cleaning and disinfection there are inherent disadvantages with any 348 
procedure.  A limitation of the 405 nm light technology is that, to ensure that patient friendly 349 
room illumination conditions are used, relatively low irradiance levels are applied and this 350 
impacts on microbial inactivation rates which are inevitably lower than can be achieved with 351 
other decontamination technologies albeit only in short term comparisons.  The high doses of 352 
405 nm light required for inactivation of endospores means it is unlikely that 405 nm light alone 353 
could be realistically applicable for the specific environmental decontamination of C. difficile 354 
spores, however enhancement of the inactivation may be achieved when combined with other 355 
decontamination methods such as oxidative biocides, due to the similar oxidative damage that is 356 
exerted on the bacteria by both treatments.33  In addition to the resilience of spores, the 357 
antiviral efficacy of violet-blue light has not been fully established, therefore further research in 358 
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this area is required.  Also, similar to UVC technology, 405 nm light effectively treats hospital air, 359 
but only surfaces that are directly or reflectively exposed to the light are treated, and the effects 360 
on occluded or darkly shadowed areas are limited. It is also the case that whilst all of the new 361 
technologies including 405 nm light can claim to have demonstrated enhanced disinfection of 362 
the hospital environment translation of this potential benefit into a significant reduction in 363 
infection rates will be required to ensure the widespread uptake of these new disinfection 364 
technologies. 365 
Further commentary regarding the application of 405 nm light for hospital 366 
disinfection 367 
Regarding the deployment of the HINS-light system within hospitals, although important issues 368 
such as disinfection efficacy and patient safety have been addressed, other questions relating to 369 
the use of such a novel light source in clinical settings must also be considered.  Undoubtedly 370 
enrichment of room lighting with additional violet-blue light will alter the normal lighting effect. 371 
This could have some impact on patient and staff comfort levels, and possible effects on medical 372 
procedures that involve colour perception must also be considered.  In the hospital trials 373 
already conducted with the HINS-light EDS no such issues have been problematic (unpublished 374 
observations) but monitoring for such effects must remain during uptake of this technology.  375 
Further hospital-based studies, funded by the Scottish Infection Research Network and the Chief 376 
Scientist Office, are currently being initiated to investigate the acceptability of the technology, 377 
and to ensure the technology is optimised with staff and patient comfort fully taken into 378 
account.  There may conceivably also be implications for colours employed in hospital 379 
furnishings and fabrics as these may serve to amplify or supress the reflection or absorption of 380 
violet-blue light. 381 
As already discussed, a benefit of 405 nm light over UV-light for disinfection purposes is that, 382 
unlike UV-light, 405 nm light, because of its lower photon energy, does not cause photo-383 
degradation of photosensitive materials such as rubbers and plastics used in the hospital 384 
environment and equipment.69  However strong visible light can cause photochemical changes 385 
in light-sensitive solutions, and this aspect requires consideration if such solutions were to be 386 
exposed for long periods.  At the relatively low 405 nm light intensities used58-60, and 387 
considering the fact that light intensity reduces upon transmission through materials e.g. plastic 388 
tubing or IV bag material, then this issue is not anticipated to be problematic but nevertheless 389 
must remain a consideration if highly light-sensitive pharmaceuticals were introduced. 390 
The HINS-light system utilises LED-based technology and as such it benefits from the well-391 
established characteristics of LED lighting, namely reduced energy requirements, long 392 
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operational (lifetime) use, and low maintenance characteristics.  In the hospital trials already 393 
conducted, the HINS-light EDS unit is designed to be easily retrofitted into the ceiling in place of 394 
a ceiling tile.  Installed units have remained maintenance-free and fully-operational over the 395 
trial period which now extends to several years.  From a lighting technology perspective, it is 396 
interesting that the introduction of this LED-based disinfection system is concurrent with major 397 
potential changes taking place in general lighting technology.  Considerable debate is underway 398 
regarding the advantages and disadvantages of replacing conventional fluorescent lighting with 399 
LED sources, a discussion that is mainly being driven by potential energy efficiency gains 400 
associated with LED lighting.  Another potential advantage of LED technology is the capacity to 401 
blend    Ǯ ǯ        402 
applications.  In this context it is interesting that it is now appreciated, and as previously 403 
discussed in this review, that the nature of the light spectrum can affect circadian rhythmicity, 404 
sleep and mood and that this is associated with photosensitive retinal ganglion cells in the eye.76  405 
Such effects are not only important in the home and workplace but also for patients in the 406 
hospital environment, where it has been suggested that more research is required to better 407 
understand how lighting in the hospital environment can influence sleep, mood and pain in 408 
medical inpatients.22  Future development of the HINS-light EDS system will undoubtedly be 409 
influenced by the various considerations outlined above. 410 
Conclusions 411 
Although the germicidal effects of sunlight and UV-light have been known for well over a 412 
century it is only comparatively recently that the antimicrobial properties of visible light in the 413 
violet-blue region of the spectrum have been recognised and studied in a number of 414 
laboratories. Given the severity of current and anticipated future microbiological problems 415 
faced by society, the development of any new antimicrobial weapon is to be welcomed. Violet-416 
blue light, with particular efficacy at 405 nm, has been shown to possess broad spectrum 417 
photodynamic antimicrobial activity, and as such its use has been suggested for a range of 418 
potential clinical and medical applications.   419 
One such application is the use of 405 nm light for environmental disinfection.  The increased 420 
safety of 405 nm light wavelengths compared to UV-light, has facilitated development of this 421 
light technology for safe continuous disinfection of occupied environments, and results have 422 
shown the successful application of this system for environmental disinfection of hospital 423 
isolation rooms.  This technology termed, the HINS-light EDS, has demonstrated a significant 424 
capability for reducing environmental bacterial contamination in clinical patient areas, over and 425 
above reductions achieved using the conventional cleaning and infection control strategies 426 
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alone.  In common with the aspirations of other novel whole room disinfection systems, it is 427 
intended that this intervention technology, when used in conjunction with conventional 428 
infection control procedures, can help reduce levels of pathogens in the environment, thereby 429 
limiting the likelihood of pathogen transmission from the environment to patients, and thus 430 
contribute to reducing levels of HAIs. 431 
Whilst violet-blue 405 nm light irradiation represents a new antimicrobial approach, the 432 
physical nature of this light source and the limitations of its antimicrobial effects must be 433 
understood. Inevitably microbial inactivation rates using 405 nm light are slower than can be 434 
achieved with the typical application of many other physical and chemical disinfection and 435 
sterilisation treatments. This limitation is however mitigated by its operational facility for 436 
continuous application to disinfect air and all illuminated surfaces in occupied environments 437 
and by the biochemical mechanism of 405 nm light inactivation. The photodynamic inactivation 438 
process induced by 405 nm light exposure involves a multi-targeted intracellular killing effect 439 
resulting from the generation of reactive oxygen species, a killing mechanism that is not 440 
conducive to microbial resistance development. Given these unique features, it is evident that 441 
405 nm violet-blue light technology represents a novel antimicrobial approach that hopefully 442 
can make some contribution to tackling the challenge posed by ubiquitous environmental 443 
contamination, and to the ongoing health and resource problems associated with healthcare-444 
associated infections (HAI). 445 
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Table I.  Comparison of the properties of ultraviolet C (UVC) and 405 nm light for environmental 663 
disinfection applications. 664 
 UVC LIGHT 405nm LIGHT 
Typical/Potential use Terminal clean of air and light 
exposed surfaces 
Continuous disinfection of air 
and light exposed surfaces 
Safety Significant safety hazards 
associated with human 
exposure; can cause DNA 
mutations, erythema 70 
Can be utilised safely in the 
presence of people at 
recommended irradiation levels 
58-60 
Mechanism of Action DNA damage kills cells.            
Sub-lethally damaged cells can 
recover using photoreactivation 
mechanism to repair DNA 71,72 
Photoexcitation of intracellular 
molecules induces oxidation of 
microbial cells.                                
No known repair mechanism 73,74 
Antimicrobial Activity Broad spectrum action against a 
range of microorganisms 
including spores and viruses 
51,52 
Effective against bacteria, fungi, 
yeasts and spores; antiviral 
activity not yet fully established 
32,33,56 
Antimicrobial Efficacy Rapid inactivation rate within 
treatment zone 6,24 
Comparably slower inactivation 
rate within treatment zone 58-60 
Materials Compatibility UV light associated polymer 
damage 69 
Lower energy 405 nm 
wavelengths more materials 
compatible 69 
Ease of Use for 
Environmental 
Disinfection 
Rooms/wards need to be 
vacated during use; operator 
training required 6,24 
Can be safely used during room 
occupation; no operator safety 
training required 58-60 
Microbial Mutagenic 
Potential 
Powerful mutagen that may 
encourage resistance 
development  
Multi-target oxidative action 
mitigates against resistance 
development 75 
Penetrability Does not penetrate through 
plastics and glass and weakly 
penetrates into water and 
fabrics 
Can penetrate through plastics 
and glass and penetrates into 







Figure Legends 669 
 670 
Figure 1.  UV, visible light and infrared regions of the electromagnetic spectrum.  Highlighted are 671 
key UV and violet/blue wavelengths with detail of their germicidal action and safety aspects. 672 
 673 
Figure 2.  Mean reductions in the total staphylococcal counts and the presumptive S. aureus levels 674 
across an occupied burns unit isolation room, before, during and after 5-day use of HINS-light EDS. 675 
Contact plate samples (n=70) were collected twice during each phase and the results pooled to 676 
assess the overall decontamination effect.  A significant 62% decrease in total staphylococcal 677 
counts, and 50% decrease in presumptive S. aureus was achieved (P<0.05).  Ǯ ǯ ǡ678 
showed that contamination around the room had significantly risen over the 6-days after the 679 
system was switched off: 126% and 98% increase in the total staphylococci and presumptive 680 
S. aureus counts, respectively (P<0.05).  (Data adapted from 53). 681 
 682 
Figure 3. Reductions in the mean levels of environmental bacteria on a range of surfaces in an ICU 683 
isolation room before and after 5-day use of the HINS-light EDS.  Tryptone soya agar contact plate 684 
samples were collected from each surface and results pooled to show the mean reduction in 685 
contamination on the sampled surface (data adapted from 55). 686 
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